Trials / Withdrawn
WithdrawnNCT03762603
Does Supplementing of Quadriceps Strength With Exoskeleton After Total Knee Arthroplasty in High Risk Population Reduce Transfer to Extended Care Facility (ECF)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study involves an exoskeleton which is believed to increase quadriceps muscle strength in the rehabilitation phase after TKA and reduce the discharge the such patients in Extended care facility (ECF) . The purpose of this study is to access efficacy of the robotic exoskeleton device wrapped around the operated knee on patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Robotic exoskeleton device | It is a non invasive and non significant risk medical device which wraps around operated knee to support motion. |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2025-12-20
- Completion
- 2027-12-20
- First posted
- 2018-12-04
- Last updated
- 2025-04-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03762603. Inclusion in this directory is not an endorsement.